Triple X Syndrome News and Research

RSS
Study: Noninvasive prenatal testing detects 83.2% of chromosomal abnormalities

Study: Noninvasive prenatal testing detects 83.2% of chromosomal abnormalities

BGI Health to introduce NIFTY screening test to reduce miscarriages

BGI Health to introduce NIFTY screening test to reduce miscarriages

DASA Group to offer Natera's non-invasive prenatal test for detection of genetic syndromes

DASA Group to offer Natera's non-invasive prenatal test for detection of genetic syndromes

Discovery provides evidence that genetic defect responsible for Down syndrome can be suppressed

Discovery provides evidence that genetic defect responsible for Down syndrome can be suppressed

PrenaTest can be now performed for high risk pregnancies after ninth week

PrenaTest can be now performed for high risk pregnancies after ninth week

UNIGE researchers identify genomic variations associated with trisomy 21

UNIGE researchers identify genomic variations associated with trisomy 21

Study: Non-invasive blood test could reshape standards in prenatal testing

Study: Non-invasive blood test could reshape standards in prenatal testing

Echevarne to distribute Natera's non-invasive prenatal screening test in Spain

Echevarne to distribute Natera's non-invasive prenatal screening test in Spain

Verinata Health provides follow-up data on Verifi prenatal test

Verinata Health provides follow-up data on Verifi prenatal test

New partnership to introduce advanced genetic testing technologies to Turkey

New partnership to introduce advanced genetic testing technologies to Turkey

High levels of blood cholesterol increase risk of AD and heart disease

High levels of blood cholesterol increase risk of AD and heart disease

Researchers complete phase II clinical trial of dasatinib for patients with higher-risk MDS

Researchers complete phase II clinical trial of dasatinib for patients with higher-risk MDS

Non-invasive prenatal genetic screening: an interview with Dr. Charles Strom, Senior Medical Director, Quest Diagnostics

Non-invasive prenatal genetic screening: an interview with Dr. Charles Strom, Senior Medical Director, Quest Diagnostics

Quest Diagnostics offers access to a new non-invasive prenatal test developed by Natera

Quest Diagnostics offers access to a new non-invasive prenatal test developed by Natera

Clonal evolution explains unpredictable leukemia disease course

Clonal evolution explains unpredictable leukemia disease course

Ultrasound signs can predict Down’s syndrome

Ultrasound signs can predict Down’s syndrome

Sequencing-based test effectively detects many fetal genetic defects

Sequencing-based test effectively detects many fetal genetic defects

GENNET, BGI enter collaborative agreement for non-invasive fetal trisomy test

GENNET, BGI enter collaborative agreement for non-invasive fetal trisomy test

Study documents women's experiences after abnormal prenatal chromosomal microarray testing

Study documents women's experiences after abnormal prenatal chromosomal microarray testing

Fetal fraction of cfDNA does not vary significantly among pregnant women regardless of trisomy risk

Fetal fraction of cfDNA does not vary significantly among pregnant women regardless of trisomy risk